Cystic fibrosis in the crosshairs as Carbon Biosciences launches with $38M funding
Carbon Biosciences, a Longwood Fund founded biotech company developing parvovirus-derived gene therapies, has launched with…
June 22, 2022 - 3 minutes
Carbon Biosciences, a Longwood Fund founded biotech company developing parvovirus-derived gene therapies, has launched with…